Advertisement
Screener

Amphastar Pharmaceuticals, Inc. (AMPH) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

2.5 / 5 stars · 60/120 Roast Me

Amphastar Pharmaceuticals, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

Amphastar Pharmaceuticals, Inc. (AMPH) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$168.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06

  • Amphastar Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$168.00K, a 106.44% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$422.00K, a 134.82% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was -$41.00K.
  • Amphastar Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $88.00K, a 1660.00% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $3.87M.
  • Amphastar Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$703.00K, a 581.51% decline from fiscal 2023.
  • Amphastar Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $146.00K.
  • Amphastar Pharmaceuticals, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$1.86M.
Period endOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month
2026-06-30-$168.00K
10-Q · filed 2026-08-06
-$590.00K
10-Q · filed 2026-08-06
-$631.00K
derived: sum of 3 quarters · filed 2026-08-06
-$543.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$422.00K
10-Q · filed 2026-08-06
-$463.00K
derived: sum of 2 quarters · filed 2026-08-06
-$375.00K
derived: sum of 3 quarters · filed 2026-08-06
$2.23M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$41.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$47.00K
derived: sum of 2 quarters · filed 2026-02-26
$2.65M
derived: sum of 3 quarters · filed 2026-08-06
$3.87M
10-K · filed 2026-02-26
2025-09-30$88.00K
10-Q · filed 2025-11-06
$2.70M
derived: sum of 2 quarters · filed 2026-08-06
$3.91M
10-Q · filed 2025-11-06
$3.55M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$2.61M
10-Q · filed 2026-08-06
$3.82M
10-Q · filed 2026-08-06
$3.46M
derived: sum of 3 quarters · filed 2026-08-06
$3.46M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.21M
10-Q · filed 2026-08-06
$852.00K
derived: sum of 2 quarters · filed 2026-08-06
$857.00K
derived: sum of 3 quarters · filed 2026-08-06
$800.00K
derived: sum of 4 quarters · filed 2026-08-06
2024-12-31-$360.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$355.00K
derived: sum of 2 quarters · filed 2026-02-26
-$412.00K
derived: sum of 3 quarters · filed 2026-02-26
-$703.00K
10-K · filed 2026-02-26
2024-09-30$5.00K
10-Q · filed 2025-11-06
-$52.00K
derived: sum of 2 quarters · filed 2025-11-06
-$343.00K
10-Q · filed 2025-11-06
-$410.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$57.00K
10-Q · filed 2025-11-06
-$348.00K
10-Q · filed 2025-08-07
-$415.00K
derived: sum of 3 quarters · filed 2026-02-26
-$502.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$291.00K
10-Q · filed 2025-11-06
-$358.00K
derived: sum of 2 quarters · filed 2026-02-26
-$445.00K
derived: sum of 3 quarters · filed 2026-02-26
-$501.00K
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$67.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$154.00K
derived: sum of 2 quarters · filed 2026-02-26
-$210.00K
derived: sum of 3 quarters · filed 2026-02-26
$146.00K
10-K · filed 2026-02-26
2023-09-30-$87.00K
10-Q · filed 2024-11-07
-$143.00K
derived: sum of 2 quarters · filed 2024-11-07
$213.00K
10-Q · filed 2024-11-07
$1.52M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30-$56.00K
10-Q · filed 2024-11-07
$300.00K
10-Q · filed 2024-08-09
$1.61M
derived: sum of 3 quarters · filed 2025-03-03
$385.00K
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31$356.00K
10-Q · filed 2024-11-07
$1.66M
derived: sum of 2 quarters · filed 2025-03-03
$441.00K
derived: sum of 3 quarters · filed 2025-03-03
-$1.02M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
$85.00K
derived: sum of 2 quarters · filed 2025-03-03
-$1.38M
derived: sum of 3 quarters · filed 2025-03-03
-$1.86M
10-K · filed 2025-03-03
2022-09-30-$1.22M
10-Q · filed 2023-11-08
-$2.69M
derived: sum of 2 quarters · filed 2023-11-08
-$3.17M
10-Q · filed 2023-11-08
-$3.65M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$1.46M
10-Q · filed 2023-11-08
-$1.94M
10-Q · filed 2023-08-09
-$2.43M
derived: sum of 3 quarters · filed 2024-02-29
-$3.78M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$480.00K
10-Q · filed 2023-11-08
-$968.00K
derived: sum of 2 quarters · filed 2024-02-29
-$2.31M
derived: sum of 3 quarters · filed 2024-02-29
-$1.60M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$488.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$1.83M
derived: sum of 2 quarters · filed 2024-02-29
-$1.12M
derived: sum of 3 quarters · filed 2024-02-29
-$3.04M
10-K · filed 2024-02-29
2021-09-30-$1.35M
10-Q · filed 2022-11-08
-$635.00K
derived: sum of 2 quarters · filed 2022-11-08
-$2.56M
10-Q · filed 2022-11-08
-$1.80M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$711.00K
10-Q · filed 2022-11-08
-$1.21M
10-Q · filed 2022-08-09
-$453.00K
derived: sum of 3 quarters · filed 2023-03-01
$242.00K
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$1.92M
10-Q · filed 2022-11-08
-$1.16M
derived: sum of 2 quarters · filed 2023-03-01
-$469.00K
derived: sum of 3 quarters · filed 2023-03-01
-$181.00K
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$757.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$1.45M
derived: sum of 2 quarters · filed 2023-03-01
$1.74M
derived: sum of 3 quarters · filed 2023-03-01
$966.00K
10-K · filed 2023-03-01
2020-09-30$695.00K
10-Q · filed 2021-11-09
$983.00K
derived: sum of 2 quarters · filed 2021-11-09
$209.00K
10-Q · filed 2021-11-09
$1.37M
derived: sum of 4 quarters · filed 2022-03-11
2020-06-30$288.00K
10-Q · filed 2021-11-09
-$486.00K
10-Q · filed 2021-08-09
$675.00K
derived: sum of 3 quarters · filed 2022-03-11
-$950.00K
derived: sum of 4 quarters · filed 2022-03-11
2020-03-31-$774.00K
10-Q · filed 2021-11-09
$387.00K
derived: sum of 2 quarters · filed 2022-03-11
-$1.24M
derived: sum of 3 quarters · filed 2022-03-11
-$1.33M
derived: sum of 4 quarters · filed 2022-03-11
2019-12-31$1.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
-$464.00K
derived: sum of 2 quarters · filed 2022-03-11
-$561.00K
derived: sum of 3 quarters · filed 2022-03-11
-$674.00K
10-K · filed 2022-03-11
2019-09-30-$1.63M
10-Q · filed 2020-11-06
-$1.72M
derived: sum of 2 quarters · filed 2020-11-06
-$1.83M
10-Q · filed 2020-11-06
-$2.27M
derived: sum of 4 quarters · filed 2021-03-15
2019-06-30-$97.00K
10-Q · filed 2020-11-06
-$210.00K
10-Q · filed 2020-08-07
-$647.00K
derived: sum of 3 quarters · filed 2021-03-15
-$1.06M
derived: sum of 4 quarters · filed 2021-03-15
2019-03-31-$113.00K
10-Q · filed 2020-11-06
-$550.00K
derived: sum of 2 quarters · filed 2021-03-15
-$960.00K
derived: sum of 3 quarters · filed 2021-03-15
-$3.22M
derived: sum of 4 quarters · filed 2021-03-15
2018-12-31-$437.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
-$847.00K
derived: sum of 2 quarters · filed 2021-03-15
-$3.10M
derived: sum of 3 quarters · filed 2021-03-15
-$1.91M
10-K · filed 2021-03-15
2018-09-30-$410.00K
10-Q · filed 2019-11-08
-$2.67M
derived: sum of 2 quarters · filed 2019-11-08
-$1.48M
10-Q · filed 2019-11-08
-$981.00K
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30-$2.26M
10-Q · filed 2019-08-09
-$1.07M
10-Q · filed 2019-08-09
-$571.00K
derived: sum of 3 quarters · filed 2020-03-16
$54.00K
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31$1.19M
10-Q · filed 2019-05-10
$1.69M
derived: sum of 2 quarters · filed 2020-03-16
$2.31M
derived: sum of 3 quarters · filed 2020-03-16
$3.32M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$495.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$1.12M
derived: sum of 2 quarters · filed 2020-03-16
$2.13M
derived: sum of 3 quarters · filed 2020-03-16
$2.60M
10-K · filed 2020-03-16
2017-09-30$625.00K
10-Q · filed 2018-11-09
$1.64M
derived: sum of 2 quarters · filed 2018-11-09
$2.10M
10-Q · filed 2018-11-09
-$14.00K
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30$1.01M
10-Q · filed 2018-08-09
$1.48M
10-Q · filed 2018-08-09
-$639.00K
derived: sum of 3 quarters · filed 2019-03-15
-$530.00K
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31$466.00K
10-Q · filed 2018-05-10
-$1.65M
derived: sum of 2 quarters · filed 2019-03-15
-$1.54M
derived: sum of 3 quarters · filed 2019-03-15
-$2.19M
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31-$2.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
-$2.01M
derived: sum of 2 quarters · filed 2019-03-15
-$2.66M
derived: sum of 3 quarters · filed 2019-03-15
-$2.22M
10-K · filed 2019-03-15
2016-09-30$109.00K
10-Q · filed 2017-11-09
-$542.00K
derived: sum of 2 quarters · filed 2017-11-09
-$106.00K
10-Q · filed 2017-11-09
$1.18M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30-$651.00K
10-Q · filed 2017-08-09
-$215.00K
10-Q · filed 2017-08-09
$1.07M
derived: sum of 3 quarters · filed 2018-03-14
$1.44M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31$436.00K
10-Q · filed 2017-05-10
$1.72M
derived: sum of 2 quarters · filed 2018-03-14
$2.10M
derived: sum of 3 quarters · filed 2018-03-14
$2.61M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31$1.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$1.66M
derived: sum of 2 quarters · filed 2018-03-14
$2.17M
derived: sum of 3 quarters · filed 2018-03-14
-$821.00K
10-K · filed 2018-03-14
2015-09-30$374.00K
10-Q · filed 2016-11-09
$887.00K
derived: sum of 2 quarters · filed 2016-11-09
-$2.11M
10-Q · filed 2016-11-09
-$1.96M
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30$513.00K
10-Q · filed 2016-08-09
-$2.48M
10-Q · filed 2016-08-09
-$2.33M
derived: sum of 3 quarters · filed 2017-03-15
-$3.87M
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31-$2.99M
10-Q · filed 2016-05-10
-$2.84M
derived: sum of 2 quarters · filed 2017-03-15
-$4.38M
derived: sum of 3 quarters · filed 2017-03-15
-$4.65M
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31$149.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
-$1.39M
derived: sum of 2 quarters · filed 2017-03-15
-$1.65M
derived: sum of 3 quarters · filed 2017-03-15
-$1.65M
10-K · filed 2017-03-15
2014-09-30-$1.53M
10-Q · filed 2015-11-13
-$1.80M
derived: sum of 2 quarters · filed 2015-11-13
-$1.80M
10-Q · filed 2015-11-13
2014-06-30-$268.00K
10-Q · filed 2015-08-13
-$268.00K
10-Q · filed 2015-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
MANNKIND CORP (MNKD)United States$1.058B-30.41
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Jaguar Health, Inc. (JAGX)United States$1.184B
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87